Nutrigenomics Institute

09/03/2026

In recent years, medications like Ozempic (semaglutide) have become key players in the treatment of obesity and overweight. Their effectiveness in reducing appetite and facilitating weight loss has generated enthusiasm both in the medical field and on social media.   However, one key question is ge...

09/03/2026

Ozempic and weight rebound: what science really says when treatment is stopped🧐
In recent years, medications like Ozempic (semaglutide) have become key players in the treatment of obesity and overweight. Their effectiveness in reducing appetite and facilitating weight loss has generated enthusiasm both in the medical field and on social media.
However, one key question is generating increasing debate: what happens when treatment is stopped?

More information in this link and in the section NEWS of our website 🤓

In recent years, medications like Ozempic (semaglutide) have become key players in the treatment of obesity and overweight. Their effectiveness in reducing appetite and facilitating weight loss has generated enthusiasm both in the medical field and on social media.   However, one key question is ge...

02/03/2026

The New Era of Nutritional Treatment: Merging Genetic and Microbiota Data 🧐

In the latest advance in nutritional science, traditional approaches based on generalized dietary recommendations are giving way to much more personalized strategies. The central idea revolutionizing this field is the fusion of genetic testing data with gut microbiota profiles to design personalized nutritional treatments that maximize health and reduce the risk of chronic diseases
More info in this link and in teh section NEWS of our website 🤓
https://nutrigenomicsinstitute.com/nutrigenomics-news/the-new-era-of-nutritional-treatment-merging-genetic-and-microbiota-data/

23/02/2026

Barbacid’s research in Spain and the advance against pancreatic cancer
The challenge of financing the next phase. 🧐

Although the preclinical progress is remarkable, moving towards human trials requires considerable funding . Barbacid and his team have estimated that they could need around 30 million euros to advance to clinical trials and regulatory studies.

More information in this link and in the section NEWS of our website 🤓
https://nutrigenomicsinstitute.com/nutrigenomics-news/barbacids-research-and-the-advance-against-pancreatic-cancer/

16/02/2026

Genetics of human longevity: an updated summary.🧐


Longevity—understood as living longer in good health—is influenced by environmental factors, lifestyle, and genetics . Scientific studies estimate that heritability (the percentage of variation explained by genes) can be significant, ranging from approximately 25% to approximately 50% or more in recent analyses that control for external causes of mortality.

More information in this link and in the section NEWS of our website 🤓
https://nutrigenomicsinstitute.com/nutrigenomics-news/genetics-of-human-longevity-an-updated-summary/

09/02/2026

Why do some pregnancies end in miscarriage?
Scientific explanations and recent data.🧐

Miscarriage, also called pregnancy loss , is the natural termination of a pregnancy before the 20th week of gestation. Although it is often experienced in silence and rarely discussed socially, it is more common than many people realize : between 10% and 20% of clinically recognized pregnancies end in miscarriage, and the actual number could be higher if very early losses that occur before a woman knows she is pregnant are taken into account.

Recently, scientific studies have begun to identify very specific biological factors behind these losses, although a clear cause cannot always be found in every case.
More info in this link and in the section NEWS of our website. 🤓
https://nutrigenomicsinstitute.com/nutrigenomics-news/why-do-some-pregnancies-end-in-miscarriage/

02/02/2026

The silent epidemic: increased colon cancer and mortality in young people 🧐
Colorectal cancer—traditionally associated with people over 50—is experiencing an unexpected increase in incidence and mortality among young adults under 50 in several countries, especially in the United States and Europe. This has been confirmed by both medical journal reports and global epidemiological analyses.
More info in this link and in the section NEWS of our website 🤓
https://nutrigenomicsinstitute.com/nutrigenomics-news/the-silent-epidemic-increased-colon-cancer-and-mortality-in-young-people/